Navigation Links
Duffy-negative blood types no longer protected from P. Vivax malaria
Date:3/15/2010

s a major public health problem. Major efforts to fight malaria are focused on Plasmodium falciparum. While P. vivax is the second most prevalent malaria parasite, public health data on it is limited. "We did not anticipate such a widespread phenomenon when we started the study with our Malagasy colleagues from the National Malaria Control Programme. Finding vivax malaria in a group previously considered resistant adds yet another public health threat to this population. It was bad news. We need to understand how the parasite has evolved in Madagascar to spread disease to a broader population," says Dr. Didier Mnard from Pasteur Institute.

Dr. Odile Mercereau-Puijalon, Head of the Parasite Molecular Immunology Unit at the Pasteur Institute, commented, "The large numbers of P. vivax parasitized red blood cells in Duffy-negative patients shows an efficient invasion process in cells considered to be resistant to infection. This capacity is clearly not restricted to a single P. vivax strain in Madagascar and is a widespread phenomenon across the island. Our findings illustrate the extraordinary capacity of malaria parasites to overcome barriers. This calls for increased vigilance in the efforts to control malaria."

With these novel findings, the Case Western Reserve and Pasteur Institute researchers will examine how the malaria parasites successfully invade the cells and determine the molecular receptor involved in this process. Through their future studies the team hopes to determine how these parasites invade red blood cells and contribute to development of an effective vaccine against vivax malaria.


'/>"/>

Contact: Jessica Studeny
jessica.studeny@case.edu
216-368-4692
Case Western Reserve University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UF researcher urges caution in reducing blood pressure in patients with diabetes, coronary disease
2. Carnegie Mellon researchers seek to control blood loss
3. Breakthrough reveals blood vessel cells are key to growing unlimited amounts of adult stem cells
4. More evidence on benefits of high blood pressure drugs in diabetic eye disease
5. UCR researcher identifies mechanism malaria parasite uses to spread among red blood cells
6. Biologists image birth of blood-forming stem cells in embryo
7. Bacteria-killing proteins cover blood type blind spot
8. Cord blood-derived CD133+ cells improve cardiac function after myocardial infarction
9. NYSCF Fellow lead author on study that creates blood vessel cells from stem cells
10. New way to generate abundant functional blood vessel cells from human stem cells discovered
11. Blood test for schizophrenia could be ready this year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Aug. 3, 2015 Synaptics, Inc. (Nasdaq: ... today announced that members of the executive management team ... Crest Global Technology Leadership Forum on Tuesday, August 11, ... be held at the Sonnenalp Resort in ... may include forward-looking information. An audio webcast of the ...
(Date:7/31/2015)... julho de 2015 A 10 a. ... realizada pela BGI de 22-25 de outubro de 2015, em ... A conferência está celebrando seu 10 o. aniversário este ... tornou uma das reuniões mais influentes do mundo no ... dinâmicos, entusiastas e prazerosos. A ICG-10 ...
(Date:7/31/2015)... , 31. Juli 2015 Die 10. internationale Konferenz ... BGI veranstaltet und findet vom 22. bis 25. ... , statt. Die Konferenz feiert ... Start 2006 ist die ICG weltweit zu einem ... Sie ist eines der dynamischsten, enthusiastischsten und angenehmsten ...
Breaking Biology News(10 mins):A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3
... Academy of Sciences will host the Fifth Annual ... design of oligosaccharides and proteins for materials and ... on the following areas: (1) synthetic and biosynthetic ... these macromolecules in materials science and glycobiology, (2) ...
... Kidney stones strike an estimated 1 million Americans each year, ... is among the worst known to man (or woman). ... Medicine in St. Louis provides evidence to explain why some ... Their discovery opens the door to finding effective drug treatments ...
... Concordia University is bringing us one step closer to clean ... a battery-like enzyme can store energy from seconds to hours, ... Chemical Society shows. Concordia Associate Professor Lszl Klmn ... graduate students Sasmit Deshmukh and Kai Tang has been ...
Cached Biology News:Kidney stone mystery solved 2Kidney stone mystery solved 3Nature's billion-year-old battery key to storing energy 2
(Date:8/27/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading ... today announced that executives from the company will present ... , Pedro Lichtinger , Chief ... Annual Global Investment Conference on Wednesday, September 10, 2015 ... in New York City . ...
(Date:8/27/2015)... Boston, MA (PRWEB) , ... August 27, 2015 , ... ... the United States, ranking iLab Solutions as number 1,361 in growth for the three ... part of the top 0.1% fastest-growing privately held organizations in the country. , ...
(Date:8/26/2015)... KS (PRWEB) , ... August 26, 2015 , ... ... Biologic Solutions, announces today that a second US laboratory is to open in ... accordance with the continued partnership and long-term growth of research and development through ...
(Date:8/26/2015)... , Aug. 26, 2015  The Diabetes ... the University of Miami Miller School of Medicine, ... clinical trial to test for the first time ... successfully completed.  This FDA approved Phase I/II study ... transplantation and is an important first step toward ...
Breaking Biology Technology:Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4
... Sanofi-aventis announced,today that the anticoagulant Clexane(R) ... in Japan by the Ministry of Health, ... thromboembolism (VTE) in patients,undergoing orthopaedic surgery of ... total knee replacement and hip fracture surgery., ...
... MNKD ), focused on discovering, developing and,commercializing treatments for ... the Wachovia Healthcare Conference on January 30, 2008 at,2:00 ... Interested parties can access a link to the ... section of the Company,s website at, http://www.mannkindcorp.com . A ...
... Jan. 25 Cephalon, Inc., (Nasdaq:,CEPH) today announced ... has,accepted the company,s supplemental New Drug Application (sNDA) ... of,breakthrough pain in opioid-tolerant patients with chronic pain. ... will convene an advisory,committee panel on May 6, ...
Cached Biology Technology:Clexane(R)/Lovenox(R) Approved in Japan 2Clexane(R)/Lovenox(R) Approved in Japan 3Clexane(R)/Lovenox(R) Approved in Japan 4Clexane(R)/Lovenox(R) Approved in Japan 5Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application 2Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application 3
2,4,6, Trinitrophenyl hapten is conjugated to lipopolysaccharide (LPS)....
For the quantitative determination of cyclic AMP (cAMP) concentrations in cell culture supernates, serum, plasma, saliva, urine and cell lysates....
... the Flp-In System creates isogenic cell ... levels of the protein of interest. ... Figure 3 (click link below). In ... chloramphenicol-acetyl transferase (CAT) was subcloned into ...
... solvents can be used, such as water, benzene, formamide, nitrobenzene, cyclohexane, 1,4-dioxane, p-xylene, dimethyl sulfoxide, freon ... * Range: 12-position switchable: ... ... ...
Biology Products: